Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) open the trading on March 04, 2021, with a bit cautious approach as it glided -8.20% to $2.91. During the day, the stock rose to $3.21 and sunk to $2.82 before settling in for the price of $3.17 at the close. Taking a more long-term approach, CRVS posted a 52-week range of $1.01-$6.88.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.80%. This publicly-traded company’s shares outstanding now amounts to $29.50 million, simultaneously with a float of $17.12 million. The organization now has a market capitalization sitting at $109.62 million. At the time of writing, stock’s 50-day Moving Average stood at $3.85, while the 200-day Moving Average is $3.87.
Corvus Pharmaceuticals Inc. (CRVS) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Corvus Pharmaceuticals Inc.’s current insider ownership accounts for 4.98%, in contrast to 46.40% institutional ownership. According to the most recent insider trade that took place on Feb 17, this organization’s President and CEO bought 100,000 shares at the rate of 3.50, making the entire transaction reach 350,000 in total value, affecting insider ownership by 1,278,515. Preceding that transaction, on Feb 17, Company’s Director bought 1,285,714 for 3.50, making the whole transaction’s value amount to 4,499,999. This particular insider is now the holder of 8,053,298 in total.
Corvus Pharmaceuticals Inc. (CRVS) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2020 suggests? It has posted -$0.33 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at -$0.24) by -$0.09. This company achieved a return on equity of -51.44. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
Corvus Pharmaceuticals Inc.’s EPS increase for this current 12-month fiscal period is 6.80% and is forecasted to reach -1.58 in the upcoming year.
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) Trading Performance Indicators
Let’s observe the current performance indicators for Corvus Pharmaceuticals Inc. (CRVS). It’s Quick Ratio in the last reported quarter now stands at 4.40. The Stock has managed to achieve an average true range (ATR) of 0.37.
In the same vein, CRVS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.51, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -1.58 at the market close of one year from today.
Technical Analysis of Corvus Pharmaceuticals Inc. (CRVS)
[Corvus Pharmaceuticals Inc., CRVS] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 3.47% While, its Average True Range was 0.37.
Raw Stochastic average of Corvus Pharmaceuticals Inc. (CRVS) in the period of the previous 100 days is set at 3.98%, which indicates a major fall in contrast to 5.11% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 121.04% that was higher than 73.39% volatility it exhibited in the past 100-days period.